These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 27078120)

  • 1. Clinical Features Before Hematopoietic Stem Cell Transplantation or Enzyme Replacement Therapy of Children With Combined Immunodeficiency.
    Méndez-Echevarría A; Del Rosal T; Pérez-Costa E; Rodríguez-Pena R; Zarauza A; Ferreira-Cerdán A; Bravo M; Mellado MJ; López-Granados E
    Pediatr Infect Dis J; 2016 Jul; 35(7):794-8. PubMed ID: 27078120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perioperative complications in patients diagnosed with mucopolysaccharidosis and the impact of enzyme replacement therapy followed by hematopoietic stem cell transplantation at early age.
    Megens JH; de Wit M; van Hasselt PM; Boelens JJ; van der Werff DB; de Graaff JC
    Paediatr Anaesth; 2014 May; 24(5):521-7. PubMed ID: 24612129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hematopoietic Stem Cell Transplantation for Patients with Mucopolysaccharidosis II.
    Kubaski F; Yabe H; Suzuki Y; Seto T; Hamazaki T; Mason RW; Xie L; Onsten TGH; Leistner-Segal S; Giugliani R; Dũng VC; Ngoc CTB; Yamaguchi S; Montaño AM; Orii KE; Fukao T; Shintaku H; Orii T; Tomatsu S
    Biol Blood Marrow Transplant; 2017 Oct; 23(10):1795-1803. PubMed ID: 28673849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD45RA depletion in HLA-mismatched allogeneic hematopoietic stem cell transplantation for primary combined immunodeficiency: A preliminary study.
    Touzot F; Neven B; Dal-Cortivo L; Gabrion A; Moshous D; Cros G; Chomton M; Luby JM; Terniaux B; Magalon J; Picard C; Blanche S; Fischer A; Cavazzana M
    J Allergy Clin Immunol; 2015 May; 135(5):1303-9.e1-3. PubMed ID: 25282016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluoroquinolone resistance in hematopoietic stem cell transplant recipients with infectious complications.
    Bonadio M; Morelli G; Mori S; Riccioni R; Papineschi F; Petrini M
    Biomed Pharmacother; 2005 Oct; 59(9):511-6. PubMed ID: 16274955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activities of daily living in patients with Hunter syndrome: impact of enzyme replacement therapy and hematopoietic stem cell transplantation.
    Tanjuakio J; Suzuki Y; Patel P; Yasuda E; Kubaski F; Tanaka A; Yabe H; Mason RW; Montaño AM; Orii KE; Orii KO; Fukao T; Orii T; Tomatsu S
    Mol Genet Metab; 2015 Feb; 114(2):161-9. PubMed ID: 25468646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and efficacy of enzyme replacement therapy in combination with hematopoietic stem cell transplantation in Hurler syndrome.
    Grewal SS; Wynn R; Abdenur JE; Burton BK; Gharib M; Haase C; Hayashi RJ; Shenoy S; Sillence D; Tiller GE; Dudek ME; van Royen-Kerkhof A; Wraith JE; Woodard P; Young GA; Wulffraat N; Whitley CB; Peters C
    Genet Med; 2005 Feb; 7(2):143-6. PubMed ID: 15714083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hematopoietic stem cell transplantation in Taiwanese children with primary immunodeficiency.
    Yang YL; Lu MY; Jou ST; Lin KH; Lin DT
    J Formos Med Assoc; 2005 Feb; 104(2):101-6. PubMed ID: 15765164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human leucocyte antigen-identical haematopoietic stem cell transplantation in major histocompatiblity complex class II immunodeficiency: reduced survival correlates with an increased incidence of acute graft-versus-host disease and pre-existing viral infections.
    Renella R; Picard C; Neven B; Ouachée-Chardin M; Casanova JL; Le Deist F; Cavazzana-Calvo M; Blanche S; Fischer A
    Br J Haematol; 2006 Sep; 134(5):510-6. PubMed ID: 16848795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hematopoietic stem cell transplantation for children with primary immunodeficiency diseases: single center experience in Jordan.
    Amayiri N; Al-Zaben A; Ghatasheh L; Frangoul H; Hussein AA
    Pediatr Transplant; 2013 Jun; 17(4):394-402. PubMed ID: 23692601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence, risk factors, and outcome of bloodstream infections during the pre-engraftment phase in 521 allogeneic hematopoietic stem cell transplantations.
    Blennow O; Ljungman P; Sparrelid E; Mattsson J; Remberger M
    Transpl Infect Dis; 2014 Feb; 16(1):106-14. PubMed ID: 24372809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic neonatal screening for severe combined immunodeficiency and severe T-cell lymphopenia: Analysis of cost-effectiveness based on French real field data.
    Clément MC; Mahlaoui N; Mignot C; Le Bihan C; Rabetrano H; Hoang L; Neven B; Moshous D; Cavazzana M; Blanche S; Fischer A; Audrain M; Durand-Zaleski I
    J Allergy Clin Immunol; 2015 Jun; 135(6):1589-93. PubMed ID: 25840725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hematopoietic stem cell transplantation for 30 patients with primary immunodeficiency diseases: 20 years experience of a single team.
    Tsuji Y; Imai K; Kajiwara M; Aoki Y; Isoda T; Tomizawa D; Imai M; Ito S; Maeda H; Minegishi Y; Ohkawa H; Yata J; Sasaki N; Kogawa K; Nagasawa M; Morio T; Nonoyama S; Mizutani S
    Bone Marrow Transplant; 2006 Mar; 37(5):469-77. PubMed ID: 16435016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overview of 15-year severe combined immunodeficiency in the Netherlands: towards newborn blood spot screening.
    de Pagter AP; Bredius RG; Kuijpers TW; Tramper J; van der Burg M; van Montfrans J; Driessen GJ;
    Eur J Pediatr; 2015 Sep; 174(9):1183-8. PubMed ID: 25875249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary immunodeficiency disease: a retrospective study of 112 Chinese children in a single tertiary care center.
    Wu J; Zhong W; Yin Y; Zhang H
    BMC Pediatr; 2019 Nov; 19(1):410. PubMed ID: 31684895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and clinical course of viral upper respiratory tract infections in immunocompromised pediatric patients with malignancies or after hematopoietic stem cell transplantation.
    Fazekas T; Eickhoff P; Rauch M; Verdianz M; Attarbaschi A; Dworzak M; Peters C; Hammer K; Vecsei A; Pötschger U; Lion T
    J Pediatr Hematol Oncol; 2012 Aug; 34(6):442-9. PubMed ID: 22767134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for pre- and post-engraftment bloodstream infections after allogeneic hematopoietic stem cell transplantation.
    Kikuchi M; Akahoshi Y; Nakano H; Ugai T; Wada H; Yamasaki R; Sakamoto K; Kawamura K; Ishihara Y; Sato M; Ashizawa M; Terasako-Saito K; Kimura S; Yamazaki R; Kanda J; Kako S; Nishida J; Kanda Y
    Transpl Infect Dis; 2015 Feb; 17(1):56-65. PubMed ID: 25580541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Community respiratory virus infection in hematopoietic stem cell transplantation recipients and household member characteristics.
    Sams KA; Reich RR; Boyington AR; Barilec EM
    Oncol Nurs Forum; 2015 Jan; 42(1):74-9. PubMed ID: 25542323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for oral mucositis in children receiving hematopoietic cell transplantation for primary immunodeficiencies: a retrospective study.
    Bardellini E; Schumacher F; Conti G; Porta F; Campus G; Majorana A
    Pediatr Transplant; 2013 Aug; 17(5):492-7. PubMed ID: 23750582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term outcomes of systemic therapies for Hurler syndrome: an international multicenter comparison.
    Eisengart JB; Rudser KD; Xue Y; Orchard P; Miller W; Lund T; Van der Ploeg A; Mercer J; Jones S; Mengel KE; Gökce S; Guffon N; Giugliani R; de Souza CFM; Shapiro EG; Whitley CB
    Genet Med; 2018 Nov; 20(11):1423-1429. PubMed ID: 29517765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.